FDA draft guidance document may limit patient access to tests
The Association for Molecular Pathology (AMP) submitted comments to the US Food and Drug Administration on the draft guidance document titled, "Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use ...
Aug 30, 2011
0
0